spironolactone has been researched along with Angina Pectoris in 2 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Angina Pectoris: The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Peuter, OR | 1 |
Lip, GY | 1 |
Souverein, PC | 1 |
Klungel, OH | 1 |
de Boer, A | 1 |
Büller, HR | 1 |
Kamphuisen, PW | 1 |
Schröder, R | 1 |
Schüren, KP | 1 |
Biamino, G | 1 |
Meyer, V | 1 |
Sadée, W | 1 |
2 other studies available for spironolactone and Angina Pectoris
Article | Year |
---|---|
Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angina Pectoris; Angiotensin-Converting Enzyme | 2011 |
[Positive-inotropic heart effect of aldadiene-potassium (Aldactone pro injections)].
Topics: Angina Pectoris; Cardiac Catheterization; Cardiac Output; Cardiac Volume; Central Venous Pressure; H | 1971 |